Chrysin suppresses the TNF-induced increase in the secretion of plasma plasminogen activator inhibitor 1 (PAI-1), a risk factor for thrombotic diseases, from human umbilical vein endothelial cells (HUVECs). The present study aimed to determine the association between the location of the hydroxyl groups in chrysin to levels of PAI-1 in the medium of HUVEC stimulated with TNF. We cultured HUVEC for 3 h in medium containing chrysin or various flavonoids and then stimulated them with TNFα (10 ng/mL) for 12 h. Levels of PAI-1 antigen measured using ELISA showed that chrysin significantly inhibited the PAI-1 increase with an IC50 of 15.6 M. The flavones, galangin, baicalein, 5-hydroxyflavone, 6-hydroxyflavone, 7-hydroxyflavone and quercetin did not significantly inhibit the PAI-1 increase. Apigenin and luteolin were cytotoxic and thus their ability to inhibit PAI-1 production could not be evaluated. Chrysin also inhibited PAI-1 mRNA expression whereas the other compounds did not. Hydroxyl groups located in the A-5 and A-7 positions were essential for the inhibitory activity, which along with cytotoxicity, was significantly influenced by adding a third hydroxyl group.
Endothelial cells are involved in blood coagulation, fibrinolysis, vasoregulation and the selective blood barrier and are implicated in pathophysiological processes including cardiovascular diseases. Endothelial cells also synthesize plasminogen activator inhibitor-1 (PAI-1), the primary physiological inhibitor of t-PA that inhibits fibrinolysis [1] . Elevated plasma PAI-1 causes an imbalance in fibrinolytic activity that increases risk for cardiovascular disease. Endothelial cell impairment under various conditions is considered to contribute to elevated plasma PAI-1 levels [2] . Therefore, regulating endothelial PAI-1 production might serve as a useful approach to treating pathological conditions such as thrombosis and cardiovascular diseases.
Chrysin (5,7-hydroxyflavone) is a flavonoid that can be extracted from many plants and its abundance in honey and propolis from bees might contribute to their nutraceutical properties. The antiinflammatory properties of chrysin are associated with its ability to inhibit NF-B activation [3] and NF-B-dependent pathways are involved in the tumor necrosis factor (TNF)-induced signaling pathway of PAI-1 production. We recently showed that chrysin suppresses PAI-1 production induced by TNF- in HUVEC [4] and thus speculated that such suppressive activity is partly responsible for the inhibition of NF-B activation. Nevertheless, which structure is critically required for the onset of the suppressive activity remains unclear. The present study aimed to determine the effects of flavonoids with variously located hydroxyl groups on TNF-induced PAI-1 production in HUVEC and to predict the key positions of hydroxyl groups in chrysin. Figure 1 shows that TNF stimulation significantly and timedependently increased PAI-1 in HUVEC culture medium for up to 12 h. We therefore assessed the ability of various compounds to suppress this increase after 12 h. Chrysin (5,7-dihydroxyflavone) dose-dependently suppressed the PAI-1 increase in the culture medium ( Figure 2A ) without being cytotoxic up to a concentration of 30M ( Figure 2B ) with an IC50 of 15.6M ( Figure 3 ). We assessed the effects of the structurally similar flavones, galangin (3,5,7-trihydroxyflavone), baicalein (5,6,7-trihydroxyflavone), NPC Natural Product Communications 2017 Vol. 12 No. 4 499 -502 5 -hydroxyflavone, 6-hydroxyflavone, 7-hydroxyflavone, luteolin (3',4',5,7-tetrahydroxyflavone), quercetin (3,3',4',5,7-pentahydroxyflavone) and apigenin (4',5,7-trihydroxyflavone) on PAI-1 concentrations in the medium to gain insight into the influence of the hydroxyl groups in flavonoids ( Figure 2A ). Chrysin, with hydroxyl groups in the A-5 and A-7 positions, inhibited PAI-1 production, whereas flavone, of which the basic structure is identical to that of chrysin but without the hydroxyl groups, did not. Galangin and baicalein that have additional hydroxyl groups in the C and A rings at the C-3 and A-6 positions, respectively, of chrysin were neither inhibitory nor cytotoxic. None of the flavones with a single hydroxyl group in the A ring, namely 5-hydroxyflavone, 6hydroxyflavone and 7-hydroxyflavone were inhibitory or cytotoxic up to 30M. Apigenin and luteolin, each of which has a hydroxyl group in the B ring appeared to inhibit PAI-1 production, but they were cytotoxic and could not be evaluated ( Figure 2B ). Luteorin significantly decreased PAI-1 production. Unlike chrysin, PAI-1 decrease by luteolin was not dose dependent and showed clear dose-dependent cytotoxicity. On the other hand, chrysin showed dose-dependent PAI-1decrease with no cytotoxicity even at 30 M. The large proportion of inhibitory effect of luteolin on PAI-1 production must be due to the cytotoxicity. Notably, quercetin that has a hydroxyl group in the C-3 position in addition to a luteolin structure was slightly inhibitory and not cytotoxic. Figure 4 shows that only chrysin among the tested compounds dose-dependently suppressed the mRNA expression of PAI-1. These results support the conclusion obtained from the ELISA data. Chrysin was the only tested flavonoid with potent inhibitory effects indicated that the position of the hydroxyl group plays important roles in flavonoid activities and that a single hydroxyl group located at each of the A-5 and A-7 positions is critical for these effects. The down-regulation of PAI-1 should increase endothelial cell-mediated fibrinolytic activity and might help to prevent thrombotic diseases.
Some other flavonoids with hydroxyl groups at the A5 and A7 positions such as epigallocatechin gallate can inhibit TNFinduced PAI-1 production in vascular endothelial cells [5] and some non-flavonoid natural compounds also similarly inhibit PAI-1 production [6] [7] [8] . In addition, some pharmaceutical agents such as daunorubicin can attenuate the TNF-induced biosynthesis of PAI-1 in HUVEC [9] and insulin-sensitizing thiazolidinediones inhibit PAI-1 expression and secretion in TNF-stimulated vascular endothelial cells [10] . These suppressive effects might confer an additional benefits upon these therapeutic agents. However, the structural relationships among these compounds remain obscure. Further studies are required to determine the structure-activity relationship of compounds that can inhibit PAI-1. In conclusion, chrysin among the flavonoids tested herein was the most potent inhibitor of a PAI-1 increase stimulated by TNFα in the culture medium of HUVEC. A hydroxyl group at each of the A-5 and A-7 positions played an important role in this process and additional hydroxyl groups influenced the inhibitory activity and cytotoxicity. These results might provide a structural basis for understanding the inhibition of PAI-1 release from HUVEC, which could lead to the design of more effective and novel inhibitors of PAI-1 release and provide new agents for treating thrombosis.
Experimental

Materials:
Chrysin was purchased from MP Biomedicals (Santa Ana, CA, USA). Other flavones and TNF were purchased from Sigma-Aldrich (St. Louis MO, USA). The purity of all flavones was over 97%. Total PAI-1 ELISA kits were purchased from Molecular Innovations (Southfield, MI, USA). Cell Counting Kit-8 was purchased from DOJINDO (Kumamoto, Japan). All other materials were commercial products of the highest grade available.
Cell culture:
We seeded HUVEC isolated from human umbilicalcord veins as described [11] at a density of 2.0 × 10 4 cells/well of 96-well gelatin-coated plates. Flavonoids in dimethyl sulphoxide (DMSO) were added to DMEM containing 5% FBS and the cells were incubated for 3 h followed by tumor necrosis factor (TNF) (10 ng/mL) for the indicated periods. The Clinical Research Ethics Committee at Teikyo University approved the HUVEC isolation from human umbilical cords and cell culture (Permission No.12-081)
Measurement of PAI-1 concentration and cell viability:
Concentrations of PAI-1 were measured using total PAI-1 ELISA kits. Cytotoxic effects of test compounds were detected using Cell Counting Kit-8 (DOJINDO, Kumamoto, Japan). Briefly, 10 L of WST-8 solution (5 mM) was added to each well and then incubated with cells for 1 h at 37°C. The relative viability of cells was determined by measuring absorbance at 450 nm. The absorbance of control cells is expressed as one unit.
Quantitative reverse transcription (RT)-PCR:
Total RNA was extracted using RNAiso (Takara Bio Inc., Otsu, Japan). Singlestranded cDNA was synthesized using the PrimeScriptTM RT reagent kit (Takara Bio Inc., Otsu, Japan). Real-time RT-PCR preceded using SYBR Premix Ex Taq TM II (Takara Bio Inc., Otsu, Japan) and a 7500 Real Time PCR system (Applied Biosystems, Waltham, MA, USA). The reaction conditions were 95°C for 30 s followed by 40 cycles of 95°C for 3 s, 60°C 34 s. The primers were designed by computer assistance according to the GenBank as follows. PAI-1: forward, 5'-TTC CAGTCACATTGCCATCAC-3'; reverse, 5'-TGGCCTTTGGCC TGTCA-3'. Internal control 18S rRNA: forward, 5'-GGCGTC CCCCTTA-3'; reverse, 5'-GGGCATCACAGACCTGTTATT-3'. Amounts of PAI-1 mRNA were normalized relative to that of 18S rRNA.
Statistics:
All values are expressed as means ± S.E.M. Data are expressed as means of at least 3 independent experiments with 3 replicates. The significance of differences was evaluated using Student's t-test. For multiple comparisons, data were analyzed using a one-way ANOVA followed by Tukey-Kramer multiple comparison test. P < 0.05 was considered to represent significance.
